Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2012

01.05.2012 | Original Article

Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy

verfasst von: Carla Giordano, Carlo Viscomi, Maurizia Orlandi, Paola Papoff, Alberto Spalice, Alberto Burlina, Ivano Di Meo, Valeria Tiranti, Vincenzo Leuzzi, Giulia d’Amati, Massimo Zeviani

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Ethylmalonic encephalopathy (EE) is a rare autosomal recessive disorder characterized by early onset encephalopathy, chronic diarrhoea, petechiae, orthostatic acrocyanosis and defective cytochrome c oxidase (COX) in muscle and brain. High levels of lactic, ethylmalonic and methylsuccinic acids are detected in body fluids. EE is caused by mutations in ETHE1, a mitochondrial sulphur dioxygenase. By studying a suitable mouse model, we found that loss of ETHE1 leads to accumulation of sulphide, which is a poison for COX and other enzymatic activities thus accounting for the main features of EE. We report here the first autopsy case of a child with a genetically confirmed diagnosis of EE, and compare the histological, histochemical and immunohistochemical findings with those of the constitutive Ethe1 −/− mice. In addition to COX depleted cells, widespread endothelial lesions of arterioles and capillaries of the brain and gastrointestinal tract were the pathologic hallmarks in both organisms. Our findings of diffuse vascular damage of target critical organs are in keeping with the hypothesis that the pathologic effects of ETHE1 deficiency may stem from high levels of circulating hydrogen sulphide rather than the inability of specific organs to detoxify its endogenous production.
Literatur
Zurück zum Zitat Barth M, Ottolenghi C, Hubert L et al. (2010) Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. J Inherit Metab Dis Oct 27. [Epub ahead of print] Barth M, Ottolenghi C, Hubert L et al. (2010) Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. J Inherit Metab Dis Oct 27. [Epub ahead of print]
Zurück zum Zitat Burlina A, Zacchello F, Dionisi-Vici C et al. (1991) New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet 338:1522–1523PubMedCrossRef Burlina A, Zacchello F, Dionisi-Vici C et al. (1991) New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet 338:1522–1523PubMedCrossRef
Zurück zum Zitat Cavanagh JB, Harding BN (1994) Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 117:1357–1376PubMedCrossRef Cavanagh JB, Harding BN (1994) Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 117:1357–1376PubMedCrossRef
Zurück zum Zitat Di Meo I, Fagiolari G, Prelle A, Viscomi C, Zeviani M, Tiranti V (2011) Chronic exposure to sulphide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy. Antioxid Redox Signal 5(2):353–362CrossRef Di Meo I, Fagiolari G, Prelle A, Viscomi C, Zeviani M, Tiranti V (2011) Chronic exposure to sulphide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy. Antioxid Redox Signal 5(2):353–362CrossRef
Zurück zum Zitat Dorman DC, Moulin FJ, McManus BE, Mahle KC, James RA, Struve MF (2002) Cytochrome oxidase inhibition induced by acute hydrogen sulphide inhalation: correlation with tissue sulphide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol Sci 65(1):18–25PubMedCrossRef Dorman DC, Moulin FJ, McManus BE, Mahle KC, James RA, Struve MF (2002) Cytochrome oxidase inhibition induced by acute hydrogen sulphide inhalation: correlation with tissue sulphide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol Sci 65(1):18–25PubMedCrossRef
Zurück zum Zitat Garavaglia B, Colamaria V, Carrara F, Tonin P, Rimoldi M, Uziel G (1994) Muscle cytochrome c oxidase deficiency in two Italian patients with ethylmalonic aciduria and peculiar clinical phenotype. J Inherit Metab Dis 17(3):301–303PubMedCrossRef Garavaglia B, Colamaria V, Carrara F, Tonin P, Rimoldi M, Uziel G (1994) Muscle cytochrome c oxidase deficiency in two Italian patients with ethylmalonic aciduria and peculiar clinical phenotype. J Inherit Metab Dis 17(3):301–303PubMedCrossRef
Zurück zum Zitat Garcia-Silva MT, Campos Y, Ribes A et al. (1994) Encephalopathy, petechiae, and acrocyanosis with ethylmaloni aciduria associated with muscle cytochrome c oxidase deficiency. J Pediatr 125:843–844PubMed Garcia-Silva MT, Campos Y, Ribes A et al. (1994) Encephalopathy, petechiae, and acrocyanosis with ethylmaloni aciduria associated with muscle cytochrome c oxidase deficiency. J Pediatr 125:843–844PubMed
Zurück zum Zitat Grosso S, Mostardini R, Farnetani MA et al. (2002) Ethylmalonic encephalopathy: further clinical and neuroradiological characterization. J Neurol 249(10):1446–1450PubMedCrossRef Grosso S, Mostardini R, Farnetani MA et al. (2002) Ethylmalonic encephalopathy: further clinical and neuroradiological characterization. J Neurol 249(10):1446–1450PubMedCrossRef
Zurück zum Zitat Jamroz E, Paprocka J, Adamek D et al. (2011) Clinical and neuropathological picture of ethylmalonic aciduria - diagnostic dilemma. Folia Neuropathol 49(1):71–77PubMed Jamroz E, Paprocka J, Adamek D et al. (2011) Clinical and neuropathological picture of ethylmalonic aciduria - diagnostic dilemma. Folia Neuropathol 49(1):71–77PubMed
Zurück zum Zitat Szabo C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6(11):917–935PubMedCrossRef Szabo C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6(11):917–935PubMedCrossRef
Zurück zum Zitat Tiranti V, D’Adamo P, Briem E et al. (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74(2):239–252PubMedCrossRef Tiranti V, D’Adamo P, Briem E et al. (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74(2):239–252PubMedCrossRef
Zurück zum Zitat Tiranti V, Briem E, Lamantea E et al. (2006) ETHE1 mutations are specific to ethylmalonic encephalopathy. J Med Genet 43(4):340–346PubMedCrossRef Tiranti V, Briem E, Lamantea E et al. (2006) ETHE1 mutations are specific to ethylmalonic encephalopathy. J Med Genet 43(4):340–346PubMedCrossRef
Zurück zum Zitat Tiranti V, Viscomi C, Hildebrandt T et al. (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulphide toxicity in ethylmalonic encephalopathy. Nat Med 15(2):200–205PubMedCrossRef Tiranti V, Viscomi C, Hildebrandt T et al. (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulphide toxicity in ethylmalonic encephalopathy. Nat Med 15(2):200–205PubMedCrossRef
Zurück zum Zitat Viscomi C, Burlina AB, Dweikat I et al. (2010) Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16(8):869–871PubMedCrossRef Viscomi C, Burlina AB, Dweikat I et al. (2010) Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16(8):869–871PubMedCrossRef
Zurück zum Zitat Wang R (2011) Signaling pathways for the vascular effects of hydrogen sulphide. Curr Opin Nephrol Hypert 20(2):107–112CrossRef Wang R (2011) Signaling pathways for the vascular effects of hydrogen sulphide. Curr Opin Nephrol Hypert 20(2):107–112CrossRef
Zurück zum Zitat Yang G, Cao K, Wu L, Wang R (2004) Cystathionine γ-lyase overexpression inhibits cell proliferation via H2S-dependent modulation of ERK1/2 phosphorylation and p21CIp-WAC-1. J Biol Chem 279(47):49199–49205PubMedCrossRef Yang G, Cao K, Wu L, Wang R (2004) Cystathionine γ-lyase overexpression inhibits cell proliferation via H2S-dependent modulation of ERK1/2 phosphorylation and p21CIp-WAC-1. J Biol Chem 279(47):49199–49205PubMedCrossRef
Zurück zum Zitat Yang G, Wu L, Wang R (2006) Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J 20(3):553–555PubMed Yang G, Wu L, Wang R (2006) Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J 20(3):553–555PubMed
Metadaten
Titel
Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy
verfasst von
Carla Giordano
Carlo Viscomi
Maurizia Orlandi
Paola Papoff
Alberto Spalice
Alberto Burlina
Ivano Di Meo
Valeria Tiranti
Vincenzo Leuzzi
Giulia d’Amati
Massimo Zeviani
Publikationsdatum
01.05.2012
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 3/2012
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9408-3

Weitere Artikel der Ausgabe 3/2012

Journal of Inherited Metabolic Disease 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.